Literature DB >> 15900494

Reproductive and neurological Quaking(viable) phenotypes in a severe combined immune deficient mouse background.

Tammy A Tucker1, Jean A Kundert, Alla A Bondareva, Edward E Schmidt.   

Abstract

The quaking(viable) (qkv) mutation, a spontaneous deletion of a multigenic region encompassing roughly 1 Mb at 5.9 cM on the proximal end of mouse chromosome 17, causes severe trembling in all homozygous animals and infertility in all homozygous males. Physiologically, quaking mice exhibit dysmyelination and postmeiotic spermatogenic arrest. Molecular defects in Qkv mice occur in the affected tissues, indicating the primary causes of these pathologies are cell autonomous. However, because both the reproductive and neurological defects are in immune-privileged sites and because some similar pathologies at both sites have been shown to be immune mediated, we tested whether the immune system participates secondarily in manifestation of Qkv phenotypes. The qkv mutation was bred into a severe combined immune-deficient mouse line (SCID; devoid of mature B and T cells) and penetrance of the neurological and the male sterile phenotypes was measured. Results showed that neither defect was ameliorated in the immune-deficient background. We conclude that the Qkv pathologies do not likely involve a B- or T-cell-dependent response against these immune-privileged sites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15900494      PMCID: PMC2604809          DOI: 10.1007/s00251-005-0792-4

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  39 in total

Review 1.  Mechanisms of MHC class I--restricted antigen processing.

Authors:  E Pamer; P Cresswell
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

2.  The quaking I-5 protein (QKI-5) has a novel nuclear localization signal and shuttles between the nucleus and the cytoplasm.

Authors:  J Wu; L Zhou; K Tonissen; R Tee; K Artzt
Journal:  J Biol Chem       Date:  1999-10-08       Impact factor: 5.157

3.  Genomic organization and expression analysis of the mouse qkI locus.

Authors:  T Kondo; T Furuta; K Mitsunaga; T A Ebersole; M Shichiri; J Wu; K Artzt; K Yamamura; K Abe
Journal:  Mamm Genome       Date:  1999-07       Impact factor: 2.957

4.  Nuclear translocation controlled by alternatively spliced isoforms inactivates the QUAKING apoptotic inducer.

Authors:  J Pilotte; D Larocque; S Richard
Journal:  Genes Dev       Date:  2001-04-01       Impact factor: 11.361

5.  Molecular genotyping of the mouse scid allele.

Authors:  Amy L Sealey; Nicole K Hobbs; Edward E Schmidt
Journal:  J Immunol Methods       Date:  2002-02-01       Impact factor: 2.303

Review 6.  Molecular defects in the dysmyelinating mutant quaking.

Authors:  R J Hardy
Journal:  J Neurosci Res       Date:  1998-02-15       Impact factor: 4.164

Review 7.  Restricted immune responses lead to CNS demyelination and axonal damage.

Authors:  G Mancardi; B A Hart; E Capello; H P Brok; A Ben-Nun; L Roccatagliata; D Giunti; P Gazzola; M Dono; N Kerlero de Rosbo; M Colombo; A Uccelli
Journal:  J Neuroimmunol       Date:  2000-07-24       Impact factor: 3.478

8.  Neural cell type-specific expression of QKI proteins is altered in quakingviable mutant mice.

Authors:  R J Hardy; C L Loushin; V L Friedrich; Q Chen; T A Ebersole; R A Lazzarini; K Artzt
Journal:  J Neurosci       Date:  1996-12-15       Impact factor: 6.167

9.  Contrasting effects of ENU induced embryonic lethal mutations of the quaking gene.

Authors:  R D Cox; A Hugill; A Shedlovsky; J K Noveroske; S Best; M J Justice; H Lehrach; W F Dove
Journal:  Genomics       Date:  1999-05-01       Impact factor: 5.736

10.  MUTANT MICE (QUAKING AND JIMPY) WITH DEFICIENT MYELINATION IN THE CENTRAL NERVOUS SYSTEM.

Authors:  R L SIDMAN; M M DICKIE; S H APPEL
Journal:  Science       Date:  1964-04-17       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.